A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models.

Mol Ther · 2018 · PMC5993942 · PMID 29606504

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep < 0.05actually significant

The overall survival in human clinical trials for GBM only (grade IV astrocytoma) did not reach statistical significance (p < 0.05) when divided by ACKR3/CXCR7 high versus low expression.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.